TQB3823

News alerts, weekly reports and conference planners

Company:

Sino Biopharm

Drug class:

PARP1 inhibitor, PARP2 inhibitor

Related drugs:

BRCA2 mutation	Breast Cancer	BRCA2 mutation	Breast Cancer	TQB3823 Sensitive: D – Preclinical TQB3823 Sensitive : D	TQB3823 Sensitive: D – Preclinical TQB3823 Sensitive : D
BRCA1 mutation	Breast Cancer	BRCA1 mutation	Breast Cancer	TQB3823 Sensitive: D – Preclinical TQB3823 Sensitive : D	TQB3823 Sensitive: D – Preclinical TQB3823 Sensitive : D

Associations
(2)